Sign In
MNKPF.US
Claim deadline for this case already passed by, but we can still try and file for compensation for you
D. District Columbia
Court
06 Oct 2015
Class period Start
06 Nov 2017
Class period End
27 Oct 2022
Claim deadline
Shenk, et al. v. Mallinckrodt plc et al.

Mallinckrodt agreed to pay $67,75 million to settle a securities class action lawsuit accusing the Company of deceiving investors about sales in 2015-2017 years.

The original complaint alleged that the Company:
  • on October 6, 2015, was misrepresenting the portion of Acthar sales attributable to Medicare and Medicaid;
  • in a Form 10-K filed on November 29, 2016, was making false statements relating to a Federal Trade Commission investigation;
  • from January 19, 2017, through August 8, 2017, was making a series of false and misleading statements concerning Acthar sales and prospects, including financial and Acthar-related guidance to the market.
After several years of court proceedings, Mallinckrodt agreed to settle with investors to avoid further litigation.
Alleged Offence
Other
Suspected Party
Other
Security Type
Stocks
Trade Direction
Long
Plaintiffs
State Teachers Retirement System of Ohio
Attorneys
Barrack, Rodos & Bacine
Judge
Hon.Dabney L. Friedrich
Administrator
A.B. Data Ltd
Court hearing date
02 August 2022
+$67,750,000
Total Settlement Amount
Created by Stan Vick, Scout

Mallinckrodt plc

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It oper...

    Ticker
    MNKPF.US
    CIK
    1567892
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Country
    USA
    Address
    College Business & Technology Park, Dublin, Ireland, 15